Cargando…

Personal protective equipment recommendations based on COVID-19 route of transmission

Detalles Bibliográficos
Autores principales:	Gupta, Mohit Kumar, Lipner, Shari R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172702/ https://www.ncbi.nlm.nih.gov/pubmed/32330629 http://dx.doi.org/10.1016/j.jaad.2020.04.068

Ejemplares similares

A potential hidden reservoir: The role of nail hygiene in preventing transmission of COVID-19
por: Wu, Albert G., et al.
Publicado: (2020)

Recommendations for medical student preparedness and equity for dermatology residency applications during the COVID-19 pandemic
por: Stewart, Claire R., et al.
Publicado: (2020)

Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery
por: Do, Mytrang H., et al.
Publicado: (2020)

Novel solutions for dermatologic care of geriatric patients and the role of the dermatology house call
por: Lipner, Shari R., et al.
Publicado: (2020)

Dermatologic manifestations of hydroxychloroquine therapy: A closer look at the nails
por: Lipner, Shari R., et al.
Publicado: (2020)

Recommendations on dermatologic surgery during the COVID-19 pandemic
por: Der Sarkissian, Samuel Antranig, et al.
Publicado: (2020)

Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
por: Patrì, Angela, et al.
Publicado: (2020)

Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits
por: Kwatra, Shawn G., et al.
Publicado: (2020)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
por: Yang, Qian, et al.
Publicado: (2022)

COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
por: Kansal, Naveen Kumar
Publicado: (2020)

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

COVID-19 and racial disparities
por: Shah, Monica, et al.
Publicado: (2020)

Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020)

Algorithm for the classification of COVID-19 rashes
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020)

Expansion of asynchronous teledermatology during the COVID-19 pandemic
por: Su, Mack Y., et al.
Publicado: (2020)

Optimal time for the resumption of biologics after COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

#DermTwitter and digital mentorship in the COVID-19 era
por: Zheng, David X., et al.
Publicado: (2021)

Reply to: “Personal protective equipment recommendations based on COVID-19 route of transmission”
por: Cavanagh, Gregory, et al.
Publicado: (2020)

The new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care
por: Cohen, Jeffrey M., et al.
Publicado: (2020)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

Optimizing education for dermatology residents during the COVID-19 pandemic
por: Patel, Parth, et al.
Publicado: (2020)

Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic
por: Trinidad, John, et al.
Publicado: (2020)

COVID-19 and its effect on medical student education in dermatology
por: Loh, Tiffany Y., et al.
Publicado: (2020)

Proposed approach for reusing surgical masks in COVID-19 pandemic
por: Liu, Yuangang, et al.
Publicado: (2020)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Does hydroxychloroquine combat COVID-19? A timeline of evidence
por: Alia, Erisa, et al.
Publicado: (2020)

COVID-19 can present with a rash and be mistaken for dengue
por: Joob, Beuy, et al.
Publicado: (2020)

Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020)

Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)

COVID-19: Should sexual practices be discouraged during the pandemic?
por: Yin, ZhiQiang
Publicado: (2020)

Successful implementation of phototherapy guidelines during the COVID-19 pandemic
por: Dragan, Emma, et al.
Publicado: (2021)

Expanding teledermatology educational opportunities after the COVID-19 pandemic
por: Hassan, Shahzeb, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u22gp7qgc75v2k31cmkfjvqtda